Industry Voice: Biotech stocks perform well

clock
Industry Voice: Biotech stocks perform well

Equity markets performed well in the first quarter driven by an expectation of lower corporate tax rates in the US and the potential repatriation of offshore cash and investments in infrastructure.

The S&P 500 gained 6.1%, the Dow Jones gained 5.2% and the Nasdaq Composite Index gained 10.1 (all values in USD).

In the healthcare space Swiss investment company BB Biotech earned a bottom-line profit of CHF 375 mn and its share price advanced 7.7% in CHF and 7.1% in EUR through to 31st March. Profits were generated from core positions in Incyte, Celgene and Actelion - creating a cash increase in other positions such as Novo Nordisk, Ionis and in several of its mid-sized investments. Continuing a strategy of investing in promising smaller and mid-cap companies, the group also added Five Prime Therapeutics to its portfolio in Q1. 

In the near term BB Biotech expects the healthcare reform debate in the US to simmer against a backdrop of late stage clinical trial read-outs and an increase in the number of product approvals. Further merger and acquisition activity is expected to drive performance in the sector and in particular Johnson & Johnson's acquisition of Actelion will likely deliver significant cash for BB Biotech in the second quarter.

For the remainder of 2017, the group will consider selective increases in undervalued portfolio positions and continue to add promising new smaller and mid-cap positions to its investment portfolio.

For more information, please contact Claude Mikkelsen

[email protected], +44 203 770 67 85, www.bbbiotech.com

Disclaimer

All forward-looking statements included in this release are made only as of the date of this release and BB Biotech and its directors and officers assume no obligation to update any forward-looking statements as a result of new information, future events or other factors.

More on Industry Voice

Schroders is in 'advanced talks' with Greencoat Capital regarding an acquisition

Schroders confirms talks with Greencoat Capital

Follows media speculation

clock 16 December 2021 • 1 min read
Industry Voice: The top three priorities for sustainable investing in 2022

Industry Voice: The top three priorities for sustainable investing in 2022

Jenn-Hui Tan, Head of Stewardship & Sustainable Investing, Fidelity International
clock 15 December 2021 • 5 min read
Industry Voice: Flights and visa: a brief look into international travel

Industry Voice: Flights and visa: a brief look into international travel

Holiday bookings and visa purchases are rising once more. But what are the long-term expectations for international travel?

Arthur Young
clock 30 November 2021 • 3 min read
Trustpilot